They are inversely correlated with the outcomes in HF patients with reduced ejection fraction [35] and can be used as markers of cardiac fibrosis and hypertrophy [46,130,131], vascular tone [46,130,131], gut barrier function [132], and insulin sensitivity [133]. The gene discussed is INS; the disease is hydrops fetalis.